Cargando…

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia

BACKGROUND: Iron deficiency anemia is highly prevalent in patients with chronic kidney disease and is often treated with intravenous iron. There are few trials directly comparing the safety and efficacy of different intravenous iron products. METHODS: This post-hoc analysis pooled data from 767 pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strauss, William E., Dahl, Naomi V., Li, Zhu, Lau, Gloria, Allen, Lee F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960805/ https://www.ncbi.nlm.nih.gov/pubmed/27462400 http://dx.doi.org/10.1186/s12878-016-0060-x

Ejemplares similares

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
por: Ford, David C, et al.
Publicado: (2016)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019)

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
por: Hetzel, David, et al.
Publicado: (2014)

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014)

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
por: Dahl, Naomi V, et al.
Publicado: (2017)

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
por: Vadhan-Raj, Saroj, et al.
Publicado: (2016)

A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia
por: Derman, Richard, et al.
Publicado: (2017)

Iron Sucrose Versus Oral Iron Therapy in Pregnancy Anemia
por: Neeru, Syal, et al.
Publicado: (2012)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia
por: Derman, Richard, et al.
Publicado: (2018)

Randomized Controlled Trial Comparing Ferrous Sulfate and Iron Sucrose in Iron Deficiency Anemia in Pregnancy
por: Chauhan, Neha, et al.
Publicado: (2023)

A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial
por: Auerbach, Michael, et al.
Publicado: (2019)

Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease
por: Sabe, Ramy, et al.
Publicado: (2019)

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
por: Wolf, Myles, et al.
Publicado: (2020)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review
por: Glaspy, John A, et al.
Publicado: (2020)

Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain
por: Argüelles-Arias, Federico, et al.
Publicado: (2022)

Safety and Efficacy of Intravenous Iron Sucrose versus Low Molecular Weight Iron Dextran for Treatment of Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial
por: Samsudin, Sarah, et al.
Publicado: (2020)

Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial
por: Jose, Ambily, et al.
Publicado: (2019)

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
por: Macdougall, Iain C., et al.
Publicado: (2020)

Iron deficiency and iron deficiency anemia in pregnancy
por: Malinowski, A. Kinga, et al.
Publicado: (2021)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
por: Adkinson, N Franklin, et al.
Publicado: (2017)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
por: Naqash, Amreen, et al.
Publicado: (2018)

Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery
por: Auerbach, Michael, et al.
Publicado: (2022)

Iron-Refractory Iron Deficiency Anemia
por: Yılmaz Keskin, Ebru, et al.
Publicado: (2015)

Oxidation of ferumoxytol by ionizing radiation releases iron. An electron paramagnetic resonance study
por: Petronek, Michael S, et al.
Publicado: (2022)

Oral versus intravenous iron therapy in iron deficiency anemia: An observational study
por: Das, Samarendra N., et al.
Publicado: (2020)

Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020)

Effects of Iron Sucrose and Erythropoietin on Transfusion Requirements in Patients with Preoperative Iron Deficiency Anemia Undergoing on-Pump Coronary Artery Bypass Graft
por: Jafari, Shima, et al.
Publicado: (2022)

Iron Deficiency and Iron Deficiency Anemia in Children with Febrile Seizure
por: Fallah, R, et al.
Publicado: (2013)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
por: Basha, Ahmad, et al.
Publicado: (2021)

Coexistence of Essential Thrombocythemia, Iron-Refractory Iron Deficiency Anemia and Renal Cell Carcinoma
por: Namdaroğlu, Sinem, et al.
Publicado: (2016)

Anemia and Iron Deficiency in Pregnancy
por: Krafft, Alexander, et al.
Publicado: (2012)

Iron Deficiency Anemia in Pregnancy
por: Raut, Akshara K, et al.
Publicado: (2022)

Effectiveness of AOS–iron on iron deficiency anemia in rats
por: He, Hong, et al.
Publicado: (2019)

Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron
por: Strauss, William E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qst8vffpgdq76p30elr9crl5su